The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible ...

The findings contradict previous research suggesting high-risk patients with multiple myeloma were more likely to have a ...

Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Joshua K. Sabari, MD, of NYU Langone Health discusses promising results for zongertinib in HER2-mutant NSCLC; the tyrosine ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

Objective To estimate the dose–response associations between non-occupational physical activity and several chronic disease and mortality outcomes in the general adult population. Design Systematic ...

Plants face simultaneous abiotic (drought, salinity, heat) and biotic (pathogens, pests) stresses in natural and agricultural ...

Cancer immunotherapy (also referred as immune-oncology) is the modulation of the immune system to treat cancer, with the aim of improving the host immune response against neoplastic ... If you’re an ...